XML 34 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Equity Plans
6 Months Ended
Mar. 01, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Equity Plans
Equity Plans

As of March 1, 2018, 94 million shares of our common stock were available for future awards under our equity plans.

Stock Options

 
Quarter ended
 
Six months ended
 
March 1, 2018
 
March 2, 2017
 
March 1, 2018
 
March 2, 2017
Stock options granted
1

 
4

 
2

 
6

Weighted-average grant-date fair value per share
$
18.61

 
$
8.37

 
$
18.13

 
$
8.15

Average expected life in years
5.5

 
5.5

 
5.5

 
5.5

Weighted-average expected volatility
44
%
 
47
%
 
44
%
 
47
%
Weighted-average risk-free interest rate
2.2
%
 
1.9
%
 
2.2
%
 
1.8
%
Expected dividend yield
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%

Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")

 
Quarter ended
 
Six months ended
 
March 1,
2018
 
March 2,
2017
 
March 1,
2018
 
March 2,
2017
Restricted stock award shares granted
2

 
5

 
4

 
8

Weighted-average grant-date fair value per share
$
43.21

 
$
18.67

 
$
41.51

 
$
18.52



Stock-based Compensation Expense

 
Quarter ended
 
Six months ended
 
March 1,
2018
 
March 2,
2017
 
March 1,
2018
 
March 2,
2017
Stock-based compensation expense by caption
 
 
 
 
 
 
 
Cost of goods sold
$
22

 
$
23

 
$
42

 
$
42

Selling, general, and administrative
16

 
18

 
34

 
33

Research and development
14

 
14

 
27

 
26

 
$
52

 
$
55

 
$
103

 
$
101

 
 
 
 
 
 
 
 
Stock-based compensation expense by type of award
 

 
 

 
 
 
 
Stock options
$
14

 
$
18

 
$
31

 
$
35

Restricted stock awards
38

 
37

 
72

 
66

 
$
52

 
$
55

 
$
103

 
$
101



The income tax benefit related to share-based compensation expense was $58 million and $116 million for the second quarter and first six months of 2018, respectively, and $42 million and $63 million for the second quarter and first six months of 2017, respectively. The income tax benefits related to share-based compensation expense for the periods presented prior to the second quarter of 2018 were offset by an increase in the U.S. valuation allowance. As of March 1, 2018, $402 million of total unrecognized compensation costs for unvested awards was expected to be recognized through the second quarter of 2022, resulting in a weighted-average period of 1.4 years.